Fundraising Fox

Martin Taylor

Investor

Senior Associate at F-Prime Capital Partners

London

Writes $100K – $10M checks · typically $5M

About

Martin Taylor is a Principal at F-Prime Capital focused on company building and early-stage venture capital investment in biotechnology. He has served on the founding or operational teams of five portfolio companies and holds particular interest in oncology, cardiovascular, renal, metabolic, and rare disease therapeutics. He holds a First Class BA and MSci from the University of Cambridge and a PhD from the Cancer Research UK London Research Institute and UCL, with an academic background in molecular biology, biochemistry, biophysics, and genetics.

LinkedIn ↗

Experience

  1. F-Prime CapitalPrincipalcurrent2019 — presentBoston, Massachusetts, United States
  2. Stealth rare disease companyBoard Directorcurrent2026 — present
  3. Stealth CV disease companyBoard Directorcurrent2025 — present
  4. Stealth CV disease companyBoard Observer2023 — 2025
  5. ImmutrinBoard Observercurrent2026 — present
  6. Stealth neuro companyBoard Observercurrent2025 — present
  7. ARTBIOBoard Observercurrent2021 — present
  8. ARTBIOMember of the founding team (Founding Interim COO)2021 — 2022
  9. CHARM TherapeuticsMember of founding teamcurrent2021 — present
  10. CHARM TherapeuticsBoard Observercurrent2021 — present
  11. AviadoBioBoard Observer2021 — 2026
  12. Tenpoint Therapeutics LtdBoard Observer2020 — 2024
  13. Tenpoint Therapeutics LtdMember of the founding team2020 — 2021
  14. SubIntroBoard Observer2021 — 2022
  15. MRC Laboratory of Molecular Biology (LMB)Research Scientist (Wellcome Trust Sir Henry Wellcome Postdoctoral Fellow)2016 — 2019Greater Cambridge Area
  16. Stanford University School of MedicineResearch Scientist2015 — 2016San Francisco Bay Area
  17. The Francis Crick InstituteResearch Scientist (Scientific Officer)2015London Area, United Kingdom
  18. Cancer Research UKResearch Scientist (Graduate student / Scientific Officer)2010 — 2015Clare Hall laboratories, London Research Institute
  19. Medical Research CouncilMRC Summer Student2009Laboratory of Molecular Biology, Cambridge
  20. Wellcome Trust / Cancer Research UK Gurdon InstituteBBSRC Vacation student2008Cambridge

Education

  1. University of CambridgeMaster’s Degree, Natural Sciences2009 — 2010
  2. UCLDoctor of Philosophy (Ph.D.), Molecular Biology2010 — 2015
  3. University of CambridgeBachelor’s Degree, Natural Sciences2006 — 2009

Skills & more

Biochemistry13Genetics11Cell Culture7Molecular Biology9Cell Biology8Molecular Cloning6Protein Purification5Confocal Microscopy3Cancer Research4Microscopy2Biophysics1C. elegans1
+6 moreMammalian Cell CultureHigh-Performance Liquid Chromatography (HPLC)Life SciencesCancerScienceFlow Cytometry

Languages English · German

From Martin's professional profile.

Same school

Also attended University of Cambridge621

Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)Nic LowdenInvestor at Moonfire Ventures

+ 615 more

Also attended UCL253

André DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at NorthzoneGiovanni MariggiInvestor at Medicxi

+ 247 more

Shared employers

Also worked at Immutrin3

Michael AnsteyPartner at Cambridge Innovation CapitalNihal SinhaPartner at F-Prime Capital PartnersMahesh KudariSenior Associate at SR One Capital Management

Also worked at MRC Laboratory of Molecular Biology (LMB)2

Alexander SchubertCo-founder at SciFoundersIan TomlinsonInvestor at Start Codon

Also worked at Stanford University School of Medicine73

Josephine ChenInvestor at Sequoia CapitalJeffrey FinerVenture Partner at Third Rock VenturesAlejandraChief of Staff, Investment Team at Hummingbird VenturesFrancisco GimenezInvestment Team at 8VCLan JiangPartner at Lux CapitalJeffrey DeFlavio, MDEntrepreneur in Residence at AlleyCorp

+ 67 more

Also worked at The Francis Crick Institute7

Francesco MonacaInvestor at Giant Ventures Global LlpIsabel ZhangInvestor at HCVCOlivier TakJunior Partner at Curie CapitalDr. Rabia KhanAdvisor at The First ThirtyFabio PucciPartner at Arkin CapitalMoustafaSenior Associate, Systems Design at Deep Science Ventures

+ 1 more

Deals · 1

Antlia Bioscience, Inc.Board seat

via F-Prime Capital Partners · filed Jun 2026 · $20M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at F-Prime Capital Partners

Abby Wagner
Senior Accountant at F-Prime Capital Partners
Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Wong
Associate at F-Prime Capital Partners
Alexander Pasteur
Partner at F-Prime Capital Partners
Allan Galper
Vice President & Associate General Counsel at F-Prime Capital Partners
Allison MacLeod
Venture Partner at F-Prime Capital Partners
Amber Cai
Venture Partner at F-Prime Capital Partners
Andrew Bognanni
Director of Finance at F-Prime Capital Partners